Deferred Tax Assets, Operating Loss Carryforwards of ENANTA PHARMACEUTICALS INC from 30 Sep 2012 to 30 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards.
Summary
ENANTA PHARMACEUTICALS INC quarterly Deferred Tax Assets, Operating Loss Carryforwards in USD history and change rate from 30 Sep 2012 to 30 Sep 2025.
  • ENANTA PHARMACEUTICALS INC Deferred Tax Assets, Operating Loss Carryforwards for the quarter ending 30 Sep 2025 was $14,782,000, a 103% increase year-over-year.
Source SEC data
View on sec.gov
Deferred Tax Assets, Operating Loss Carryforwards, Quarterly (USD)
Deferred Tax Assets, Operating Loss Carryforwards, YoY Quarterly Change (%)

ENANTA PHARMACEUTICALS INC Quarterly Deferred Tax Assets, Operating Loss Carryforwards (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $14,782,000 +$7,508,000 +103% 30 Sep 2025 10-K 19 Nov 2025 2025 FY
Q3 2024 $7,274,000 +$7,231,000 +16816% 30 Sep 2024 10-K 19 Nov 2025 2025 FY
Q3 2023 $43,000 -$29,062,000 -100% 30 Sep 2023 10-K 27 Nov 2024 2024 FY
Q3 2022 $29,105,000 +$26,010,000 +840% 30 Sep 2022 10-K 22 Nov 2023 2023 FY
Q3 2021 $3,095,000 +$2,234,000 +259% 30 Sep 2021 10-K 23 Nov 2022 2022 FY
Q3 2020 $861,000 30 Sep 2020 10-K 24 Nov 2021 2021 FY
Q3 2014 $2,952,000 -$5,543,000 -65% 30 Sep 2014 10-K 11 Dec 2015 2015 FY
Q3 2013 $8,495,000 -$2,466,000 -22% 30 Sep 2013 10-K 11 Dec 2014 2014 FY
Q3 2012 $10,961,000 30 Sep 2012 10-K 18 Dec 2013 2013 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.